Biopharma Culture

© Enhanc3D Genomics

How Hazel Jones is charting new horizons in genomics

By Isabel Cameron

Hazel Jones is the CEO at Enhanc3D Genomics. We sat down with her to discuss her leap of faith into 3D genomics, and how she is scaling the business and driving operational change.

© Getty Images

CPHI North America 2024

Selkirk Pharma: Adapting to regulatory shifts and market demand

By Isabel Cameron

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

© Getty Images

FDA settles ivermectin lawsuit, removes contentious COVID-19 posts

By Isabel Cameron

The FDA has agreed to permanently remove several social media posts urging people not to take ivermectin for the treatment of COVID-19, after a lawsuit brought by three doctors accused the regulatory body of interfering with their ability to practice...

© Getty Images

Hired and retired: New appointments in the pharma industry

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes.

© Getty Images

Q&A: CRB on the future of life sciences industry

By Isabel Cameron

Peter Walters is a fellow of Advanced Therapies at CRB and has 20 years of experience specializing in pharmaceutical process and facility design. We spoke to him about CRB's latest life sciences report and best practices that must be adopted across...

Follow us

Webinars